Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC). - Di Costanzo, F.; Carlini, P.; Doni, L.; Massidda, B.; Mattioli, R.; Iop, A.; Barletta, E.; Moscetti, L.; Recchia, F.; Tralongo, P.; Gasperoni, S. (British Journal of Cancer, 2005)